CN114831916A - Daily eye repair composition, preparation method and application thereof - Google Patents
Daily eye repair composition, preparation method and application thereof Download PDFInfo
- Publication number
- CN114831916A CN114831916A CN202210507515.5A CN202210507515A CN114831916A CN 114831916 A CN114831916 A CN 114831916A CN 202210507515 A CN202210507515 A CN 202210507515A CN 114831916 A CN114831916 A CN 114831916A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- mixing
- eye
- daily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 230000008439 repair process Effects 0.000 title claims abstract description 23
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims abstract description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 31
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 30
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 19
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 19
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 claims abstract description 19
- 239000002253 acid Substances 0.000 claims abstract description 19
- 229940041616 menthol Drugs 0.000 claims abstract description 19
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims abstract description 18
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 15
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 15
- 229960000458 allantoin Drugs 0.000 claims abstract description 15
- 235000010208 anthocyanin Nutrition 0.000 claims abstract description 15
- 239000004410 anthocyanin Substances 0.000 claims abstract description 15
- 229930002877 anthocyanin Natural products 0.000 claims abstract description 15
- 150000004636 anthocyanins Chemical class 0.000 claims abstract description 15
- 229920006037 cross link polymer Polymers 0.000 claims abstract description 15
- 239000000419 plant extract Substances 0.000 claims abstract description 15
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims abstract description 14
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 13
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 13
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 13
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims abstract description 13
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims abstract description 13
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims abstract description 13
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 13
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 13
- 229920000881 Modified starch Polymers 0.000 claims abstract description 13
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims abstract description 13
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 13
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000001656 lutein Substances 0.000 claims abstract description 13
- 235000012680 lutein Nutrition 0.000 claims abstract description 13
- 229960005375 lutein Drugs 0.000 claims abstract description 13
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 13
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 13
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 13
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 13
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 13
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 13
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims abstract description 12
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000002537 cosmetic Substances 0.000 claims abstract description 12
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims abstract description 12
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims abstract description 12
- VKIJBOMCWLTQBD-UHFFFAOYSA-N benzoic acid N-(2-hydroxyphenyl)propanamide Chemical compound C(C1=CC=CC=C1)(=O)O.C(CC)(=O)NC1=C(C=CC=C1)O VKIJBOMCWLTQBD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000284 extract Substances 0.000 claims description 130
- 238000002156 mixing Methods 0.000 claims description 52
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 42
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 39
- 238000003756 stirring Methods 0.000 claims description 33
- 238000010438 heat treatment Methods 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 235000013399 edible fruits Nutrition 0.000 claims description 19
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 18
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 18
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 18
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 18
- 241000723346 Cinnamomum camphora Species 0.000 claims description 18
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 18
- 229940116229 borneol Drugs 0.000 claims description 18
- 229930008380 camphor Natural products 0.000 claims description 18
- 229960000846 camphor Drugs 0.000 claims description 18
- 238000001816 cooling Methods 0.000 claims description 18
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 18
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- RWAXQWRDVUOOGG-UHFFFAOYSA-N N,2,3-Trimethyl-2-(1-methylethyl)butanamide Chemical compound CNC(=O)C(C)(C(C)C)C(C)C RWAXQWRDVUOOGG-UHFFFAOYSA-N 0.000 claims description 12
- 150000002148 esters Chemical group 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 12
- 229940089508 methyl diisopropyl propionamide Drugs 0.000 claims description 12
- CFJYNSNXFXLKNS-UHFFFAOYSA-N p-menthane Chemical compound CC(C)C1CCC(C)CC1 CFJYNSNXFXLKNS-UHFFFAOYSA-N 0.000 claims description 12
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 12
- KERBAAIBDHEFDD-UHFFFAOYSA-N n-ethylformamide Chemical compound CCNC=O KERBAAIBDHEFDD-UHFFFAOYSA-N 0.000 claims description 11
- 241000045403 Astragalus propinquus Species 0.000 claims description 10
- 241000037740 Coptis chinensis Species 0.000 claims description 10
- 235000008708 Morus alba Nutrition 0.000 claims description 10
- 240000000249 Morus alba Species 0.000 claims description 10
- 235000014037 Castanea sativa Nutrition 0.000 claims description 9
- 240000007857 Castanea sativa Species 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 9
- 244000201986 Cassia tora Species 0.000 claims description 8
- 235000014552 Cassia tora Nutrition 0.000 claims description 8
- 241000112528 Ligusticum striatum Species 0.000 claims description 8
- 244000042664 Matricaria chamomilla Species 0.000 claims description 8
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 8
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 8
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 8
- 235000006533 astragalus Nutrition 0.000 claims description 8
- 235000020710 ginseng extract Nutrition 0.000 claims description 8
- 229940054168 pomegranate fruit extract Drugs 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 7
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 6
- 229940035437 1,3-propanediol Drugs 0.000 claims description 6
- 241000951473 Schizonepeta Species 0.000 claims description 6
- KIUVQMGRTDPAFR-UHFFFAOYSA-N benzoic acid 2-hydroxy-2-phenylpropanamide Chemical compound C(C1=CC=CC=C1)(=O)O.OC(C(=O)N)(C)C1=CC=CC=C1 KIUVQMGRTDPAFR-UHFFFAOYSA-N 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 6
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 6
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 5
- 244000241838 Lycium barbarum Species 0.000 claims description 5
- 240000007164 Salvia officinalis Species 0.000 claims description 5
- 229960004756 ethanol Drugs 0.000 claims description 5
- 235000005412 red sage Nutrition 0.000 claims description 5
- 229960005150 glycerol Drugs 0.000 claims description 3
- 229940119485 safflower extract Drugs 0.000 claims description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 241000229179 Ledebouriella Species 0.000 claims 1
- 241000756042 Polygonatum Species 0.000 claims 1
- 241000220317 Rosa Species 0.000 claims 1
- 229940112950 sage extract Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 230000007794 irritation Effects 0.000 abstract description 2
- 210000003205 muscle Anatomy 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 32
- 239000000047 product Substances 0.000 description 15
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- 244000020518 Carthamus tinctorius Species 0.000 description 9
- 241000037831 Polygonatum sibiricum Species 0.000 description 8
- 239000006071 cream Substances 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 229940073140 rosa canina fruit extract Drugs 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 240000002624 Mespilus germanica Species 0.000 description 5
- 235000017784 Mespilus germanica Nutrition 0.000 description 5
- 235000000560 Mimusops elengi Nutrition 0.000 description 5
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 5
- 241001180876 Saposhnikovia Species 0.000 description 5
- 241001180873 Saposhnikovia divaricata Species 0.000 description 5
- 235000007837 Vangueria infausta Nutrition 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 244000132619 red sage Species 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- -1 methyl coptisine Chemical compound 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 102000016387 Pancreatic elastase Human genes 0.000 description 3
- 108010067372 Pancreatic elastase Proteins 0.000 description 3
- 244000294611 Punica granatum Species 0.000 description 3
- 235000014360 Punica granatum Nutrition 0.000 description 3
- 241000951376 Schizonepeta tenuifolia Species 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 235000013793 astaxanthin Nutrition 0.000 description 3
- 239000001168 astaxanthin Substances 0.000 description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 3
- 229940022405 astaxanthin Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 description 2
- XDVZNDLANFJOQR-UHFFFAOYSA-N Coptisine Natural products O=Cc1c2OCOc2ccc1C=C3/NCCc4cc5OCOc5cc34 XDVZNDLANFJOQR-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 235000000539 Rosa canina Nutrition 0.000 description 2
- 240000008530 Rosa canina Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229940093441 palmitoyl oligopeptide Drugs 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000017807 phytochemicals Nutrition 0.000 description 2
- 229930000223 plant secondary metabolite Natural products 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010044625 Trichorrhexis Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000000398 anti-amebic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 229940102480 bilberry extract Drugs 0.000 description 1
- 235000019209 bilberry extract Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000004777 chromones Chemical class 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- XYHOBCMEDLZUMP-UHFFFAOYSA-N coptisine Chemical compound C1=C2C=C(C3=C(C=C4OCOC4=C3)CC3)[N+]3=CC2=C2OCOC2=C1 XYHOBCMEDLZUMP-UHFFFAOYSA-N 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a daily eye repair composition, a preparation method and application thereof, and belongs to the technical field of eye cosmetics. The preparation is prepared from acrylic acid (acrylate)/C10-30 alkanol acrylate cross-linked polymer, allantoin, triethanolamine, butanediol, menthyl lactate, ethanol, menthol, p-hydroxyacetophenone, caprylyl hydroximic acid, ascorbyl palmitate, hydroxyphenyl propionamide benzoic acid, modified corn starch, plant extract, isopropyl palmitate, hydroxypropyl cellulose, maltodextrin, anthocyanin, lutein, 1, 2-hexanediol, phenoxyethanol, ethylhexyl glycerol and the like. The preparation is suitable for use around eyes, can quickly nourish eye muscle tissues and brighten skin around the eyes, and can penetrate into cells around the eyes to promote self-repair of cells of part of the eyes, so that the effect of eye skin care is achieved. The product is mild, has no irritation, and has high safety.
Description
Technical Field
The invention belongs to the technical field of eye cosmetics, and particularly relates to a daily eye repair composition, a preparation method and application thereof.
Background
The skin around the eyes is the weakest skin of a human body, sweat glands and sebaceous glands of the skin around the eyes are rarely distributed, elastic fibers and collagen structures are lacked in a dermis layer, nerve fibers and capillary vessels of the skin around the eyes are high in distribution density, and the eyes are heavily loaded in work; and lymph circulation and blood circulation become slower with age, blood backflow is insufficient, skin around the eyes is darker, and various problems such as accumulation of hemoglobin in connective tissues and formation of dark circles are frequent.
The related technology discloses an anti-aging eye cream containing astaxanthin nanoemulsion and a preparation method and application thereof, and the anti-aging eye cream comprises the following components: honey, self-made astaxanthin extract, modified nano pearl powder, lily essential oil, tea saponin, natural oil, milk, water, aloe powder, glutathione and glycerol. The prepared eye cream has high astaxanthin content, good skin absorption rate, excellent oxidation resistance and wrinkle resistance and high safety.
The related technology discloses a mild firming and repairing eye cream and a preparation method and application thereof, wherein the eye cream comprises the following components: retinol palmitate, palmitoyl oligopeptide, further preferred eye creams include: retinol palmitate, palmitoyl oligopeptide, radix astragali extract, rhizoma Atractylodis Macrocephalae extract, and radix Altaicae extract. The composition has good effects of removing skin wrinkles and the like, is added into a matrix to prepare eye cream, and has mild, compact and repairing effects on the skin of eyes; it also has good stability.
The eye care products disclosed in the prior art mainly have the following defects: firstly, in order to specially improve certain specific effects, a plurality of products are produced, the effects of the products are relatively single, only moisture is preserved, eye bags are reduced, only black eye circles are faded, wrinkles are improved, and the eye conditions which actually occur are complex and compared, the effects of the products cannot be considered at the same time, and the eye problems cannot be comprehensively improved; ② although the eye mask can take effect quickly, after a period of time, side effects are easy to generate, such as new problems of fat particles and the like, and the fat particles are removed by means of operations and the like, thereby further increasing the eye burden.
Disclosure of Invention
In order to solve the problems in the prior art, the invention aims to provide a daily eye repair composition, a preparation method and application thereof.
The technical scheme adopted by the invention is as follows: the daily eye repair composition is mainly prepared from the following raw materials in parts by mass:
0.5-20 parts of acrylic acid (ester)/C10-30 parts of alkyl acrylate cross-linked polymer, 0.5-4 parts of allantoin, 10-90 parts of propylene glycol, 0.05-9 parts of dipropylene glycol, 1-7 parts of triethanolamine, 10-90 parts of butanediol, 0.08-30 parts of menthyl lactate, 20-130 parts of ethanol, 0.8-60 parts of menthol, 0.8-60 parts of borneol, 0.05-5 parts of camphor, 1-7 parts of p-hydroxyacetophenone, 0.8-40 parts of 1, 3-propanediol, 0.05-4 parts of caprylyl hydroximic acid, 0.005-2.5 parts of ascorbyl palmitate, 0.08-8 parts of hydroxyphenylpropionamide benzoic acid, 0.0001-5.5 parts of glucose, 0.0001-1.5 parts of modified corn starch, 0.19-280 parts of plant extract, 0.8-12 parts of isopropyl palmitate, 0.05-1.5 parts of hydroxypropyl cellulose, 0.05-1.5 parts of maltodextrin, 0.001-12 parts of anthocyanin, 0.01-11 parts of lutein, 1-7 parts of 1, 2-pentanediol, 1-7 parts of 1, 2-hexanediol, 0.05-8 parts of methyl diisopropyl propionamide, 0.05-8 parts of glycerol, 0.8-12 parts of menthane formyl ethylamine, 1-10 parts of phenoxyethanol, 0.05-8 parts of ethyl hexyl glycerol and 5-35 parts of water.
Preferably, the composition is mainly prepared from the following raw materials in parts by mass:
acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer 1-10 parts, allantoin 1-2 parts, propylene glycol 20-80 parts, dipropylene glycol 0.1-7 parts, triethanolamine 2-5 parts, butanediol 20-80 parts, menthyl lactate 1-20 parts, ethanol 30-100 parts, menthol 1-50 parts, borneol 1-50 parts, camphor 0.1-3 parts, p-hydroxyacetophenone 2-5 parts, 1, 3-propanediol 1-30 parts, caprylyl hydroximic acid 0.1-2 parts, ascorbyl palmitate 0.01-2 parts, hydroxyphenylpropionamide benzoic acid 0.1-6 parts, glucose 0.001-5 parts, modified corn starch 0.001-1 part, plant extract 0.28-200 parts, isopropyl palmitate 1-10 parts, hydroxypropyl cellulose 0.1-1 part, 0.1-1 part of maltodextrin, 0.01-10 parts of anthocyanin, 0.1-10 parts of lutein, 2-5 parts of 1, 2-pentanediol, 2-5 parts of 1, 2-hexanediol, 0.1-5 parts of methyl diisopropyl propionamide, 0.1-5 parts of glycerol, 1-10 parts of menthane formyl ethylamine, 2-8 parts of phenoxyethanol, 0.1-5 parts of ethylhexyl glycerol and 10-30 parts of water.
Preferably, the plant extract includes a combination of salvia miltiorrhiza extract, pomegranate fruit extract, rosa canina fruit extract, castanea sativa seed extract, cassia tora seed extract, mulberry fruit extract, astragalus mongholicus extract, safflower carthamus extract, coptis chinensis extract, ligusticum wallichii extract, ginseng extract, polygonatum sibiricum extract, saposhnikovia divaricata extract, cranberry fruit extract, schizonepeta cataria extract, lycium barbarum extract and chamomile flower extract.
Extract of Salvia MILTIORRHIZA (Salvia Miltiorrhiza): promoting endothelial repair, relieving inflammation, increasing capillary network opening amount, and increasing blood flow rate and flow rate, thereby improving microcirculation disturbance.
Pomegranate (PUNICA GRANATUM) fruit extract: the skin care product has the effects of resisting oxidation, diminishing inflammation, resisting bacteria and the like, and the effective components are anthocyanin, pomegranate polyphenol and ellagic acid which are extremely strong antioxidant substances and can effectively delay skin aging, preserve moisture and resist wrinkles.
Rosa CANINA (ROSA CANINA) fruit extract: the compound has proliferative activity on vascular endothelial cells, can enhance the strength of blood vessels and prevent red blood filaments of skin, and has the effect of increasing the content of ceramide in sebum and softening skin; inhibiting elastase, resisting wrinkle, and resisting aging by combining DOD-like activity.
Castanea sativa (CASTANEA SATIVA) seed extract: has good oxidation resistance, strong scavenging effect on various free radicals, and can be used as antioxidant for cosmetics; has effects in inhibiting elastase activity, slowing down elastin degradation, maintaining skin elasticity, and resisting aging.
Semen Cassiae (Cassia TORA) seed extract: has effects in regulating skin, tranquilizing mind, and relieving fatigue.
Mulberry (MORUS ALBA) fruit extract: contains reducing sugar, pentosan, galactoside, tannin, flavone, etc. Can inhibit elastase, and has antiaging effect; promoting the synthesis of fiber bud cell brain amide and softening and moistening skin; can well prevent and treat acne caused by high androgen; has contraction effect on collagen fiber, and can be used for reducing weight; promoting the activation of luciferase, and showing that the luciferase has anti-inflammatory efficacy; can inhibit tyrosinase activity, and has skin whitening effect.
Extract of Astragalus MONGHOLICUS (Astragalus MEMBRANACEUS MONGHOLICUS): has good skin compatibility and high polysaccharide content, and is a good film forming component. Can be used as emulsion stabilizer, skin film forming agent, and viscosity control agent.
Safflower (CARTHAMUS TINCTORIUS) extract: the natural pigments such as safflower yellow and safflower red extracted from safflower are safe and edible and can be used as coloring agent of high-grade cosmetics; the Carthami flos extract has effects of promoting blood circulation, resisting inflammation, resisting oxidation, whitening skin, preventing sunburn and resisting aging by improving skin blood circulation, promoting skin metabolism, scavenging free radicals, inhibiting melanin deposition, accelerating speckle and decolorizing, and absorbing ultraviolet, and can be used for treating contact dermatitis, seborrheic dermatitis, pruritus, and neurodermatitis; the safflower oil can be used as oily raw material of cosmetics to deeply supplement various nutritional ingredients of skin.
Extract of COPTIS CHINENSIS (COPTIS CHINENSIS): contains berberine, coptisine, methyl coptisine, tetrandrine, etc., and can be used for treating acute conjunctivitis, acute bacillary dysentery, acute gastroenteritis, hematemesis, carbuncle, furuncle, sore, and ulcer. Antibacterial, antifungal, antiviral, anti-amoebic, antiinflammatory, anti-diarrhea, cardiovascular, antipyretic, hypoglycemic, antioxidant, and blood system affecting effects. The product is mainly used for skin conditioning, antioxidation and sterilization in cosmetics.
Rhizoma Chuanxiong (Ligusticum CHUANXIONG) extract: can inhibit the generation of free radicals and effectively eliminate oxygen free radicals; at lower concentration, the activity of melanocyte can be effectively inhibited, and the generation of melanin is reduced, but the cytotoxicity effect is shown when the concentration is too high; it also has moisture absorption and moisture keeping effects.
GINSENG (PANAX GINSENG) extract: it can delay skin aging, prevent skin from drying and dehydrating, and increase skin elasticity, thereby protecting skin luster and tenderness, and preventing and reducing skin wrinkle, and the Ginseng radix active substance also has melanin reduction inhibiting effect, and can whiten and smooth skin. The hair conditioner can expand the capillary vessels of the head, increase the nutrition of the hair, improve the toughness of the hair, reduce the hair loss and the hair breakage and has the protection effect on the damaged hair.
Rhizoma Polygonati (Polygonatum SIBIRICUM) extract: in the culture of fiber bud cells and the like, the collagen proliferation is well promoted, so that the metabolism of the dermal layer of the skin can be enhanced, and the collagen anti-aging cosmetic has oxidation resistance and can be used in cosmetics for activating the skin and resisting wrinkles; has effects in promoting proliferation of vascular endothelial cells, strengthening and solidifying capillary vessels, and can be used for preventing and treating red blood streak.
Saposhnikovia DIVARICATA (Saposhnikovia DIVARICATA) extract: contains many coumarin compounds and chromone compounds. A small amount of the divaricate saposhnikovia root volatile oil is used for preparing essence; in the test of fat cell hydrolysis in a test tube, the radix Saposhnikoviae extract has effect in promoting fat hydrolysis, and can be used for weight reducing product; has effects in scavenging free radicals, and can be used as antioxidant; has certain inhibiting effect on melanin, and can be used as whitening product; can shrink pores, and can be used as astringent; it also has antibacterial and anti-inflammatory effects.
Bilberry (Vaccinium VITIS-IDAEA) fruit extract: can effectively prevent the formation of melanin in European clothes, and has whitening effect.
Herba Schizonepetae (SCHIZONEPETA TENUIFOLIA) extract: can be used for improving skin water metabolism and relieving skin aging.
Extract of Lycium barbarum (Lycium CHINENSE): has strong oxidation resistance. It has an oxidative radical absorption capacity of 25,000 (relative to blueberry 2,500), and is rich in calcium, potassium, iron, zinc, selenium, vitamin B and vitamin C. A study in China in 1991 showed that phytochemicals (phytochemicals) in Lycium barbarum can help prevent oxidation of DNA and restore damaged DNA.
Camomile (CHAMOMILLA RECUTITA) flower extract: can well relieve skin, resist skin sensitivity, and has antiinflammatory, antibacterial and antioxidant effects. The effects of soothing and deeply moisturizing can play a role in quickly relieving the skin problems.
A daily eye repair preparation made from the daily eye repair composition.
A method of preparing a daily eye repair formulation, the method of preparation comprising:
s1, selecting butanediol and menthyl lactate according to corresponding mass parts, mixing, heating and stirring until the menthyl lactate is completely dissolved, and obtaining a preparative phase A;
s2, selecting ethanol, menthol, borneol and camphor according to corresponding parts by weight, and mixing uniformly until the menthol, the borneol and the camphor are completely dissolved to obtain a prepared phase B;
s3, selecting p-hydroxyacetophenone, 1, 3-propylene glycol and caprylyl hydroximic acid according to corresponding parts by weight, mixing, heating and stirring until the p-hydroxyacetophenone and the caprylyl hydroximic acid are completely dissolved to obtain a prepared phase C;
s4, selecting glucose, modified corn starch, plant extract, isopropyl palmitate, hydroxypropyl cellulose, maltodextrin, anthocyanin and lutein according to corresponding parts by weight, mixing, adding deionized water, stirring until the mixture is completely dissolved, and filtering to obtain a preliminary phase D;
s5, selecting water and acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer according to corresponding mass parts, mixing the mixture to a uniform water solution, adding allantoin, propylene glycol and dipropylene glycol, stirring, heating, homogenizing, cooling to 55-60 ℃, adding triethanolamine, mixing, and defoaming; cooling to 50-55 deg.C, adding the preparative phase A and the preparative phase C, and mixing for 10-13 min; cooling to 40-45 deg.C again, adding preparative phase B, preparative phase D, ascorbyl palmitate, hydroxyphenyl propionamide benzoic acid, 1, 2-pentanediol, 1, 2-hexanediol, methyl diisopropyl propionamide, glycerol, menthane formyl ethylamine, phenoxyethanol and ethylhexyl glycerol, mixing for 20-28min, and filtering.
In the preparation process, the raw materials play the following roles:
solvent and humectant efficacy: water, allantoin (skin protectants and anti-irritants), dipropylene glycol, butylene glycol, ethanol, glucose, and glycerol;
wetting agent: propylene glycol, 1, 3-propanediol;
film-forming agent: acrylic acid (ester)/C10-30 alkanol acrylate crosspolymer, modified corn starch;
complexing agent and stabilizer: triethanolamine, caprylyl hydroxamic acid;
a cooling agent: menthyl lactate, menthane formylethylamine;
antioxidant, anti-aging agent: borneol, p-hydroxyacetophenone, ascorbyl palmitate, plant extracts (salvia miltiorrhiza extract, pomegranate fruit extract, rosa canina fruit extract, castanea sativa seed extract, cassia tora seed extract, mulberry fruit extract, astragalus mongholicus extract, safflower carthamus extract, coptis chinensis extract, ligusticum wallichii extract, ginseng extract, polygonatum sibiricum extract, saposhnikovia divaricata extract, bilberry fruit extract, schizonepeta herb extract, lycium barbarum extract and chamomile flower extract), anthocyanin and lutein;
a allergy-relieving agent: menthol, hydroxyphenylpropionamide benzoic acid;
preservative: camphor, phenoxyethanol;
solubilizer: 1, 2-pentanediol, 1, 2-hexanediol;
emulsifier: methyl diisopropyl propionamide;
softening agent: ethyl hexyl glycerol;
nonionic surfactant: isopropyl palmitate;
thickening agent: hydroxypropyl cellulose (emulsifier, surfactant), maltodextrin.
Preferably, in the S1, the heating temperature is 40-45 ℃, and the stirring is carried out for 8-10 min;
in the step S2, the mixing time is 20-25 min.
Preferably, in the S3, the heating temperature is 60-70 ℃, and the heating and stirring time is 10-15 min;
in the step S4, the stirring time is 30-35 min.
Preferably, in the S5, the mixing time of the water and the acrylic/C10-30 alkanol acrylate crosslinked polymer is 10-15 min;
stirring the allantoin, the propylene glycol and the dipropylene glycol for 5-8min when heating; heating to 75-85 deg.C for 20-25 min;
the homogenizing treatment time is 3-5min, and the rotating speed is 2000-4000 r/min.
Preferably, in the S5, the filter cloth passes through 200-250 meshes.
An application of a daily eye repairing preparation in preparing eye cosmetics.
The invention has the beneficial effects that:
the invention provides a daily eye repair preparation which is prepared from acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, allantoin, propylene glycol, dipropylene glycol, triethanolamine, butanediol, menthyl lactate, ethanol, menthol, borneol, camphor, p-hydroxyacetophenone, 1, 3-propanediol, caprylyl hydroximic acid, ascorbyl palmitate, hydroxyphenylpropionamide benzoic acid, glucose, modified corn starch, plant extracts (salvia miltiorrhiza extract, pomegranate fruit extract, rosa canina fruit extract, europaea seed extract, cassia seed extract, mulberry fruit extract, astragalus mongholicus extract, safflower carthamus extract, coptis chinensis extract, ligusticum wallichii extract, ginseng extract, polygonatum sibiricum extract, saposhnikovia divaricata extract, bilberry extract, schizonepeta tenuifolia extract, medlar extract and chamomile flower extract), Isopropyl palmitate, hydroxypropyl cellulose, maltodextrin, anthocyanin, lutein, 1, 2-pentanediol, 1, 2-hexanediol, methyl diisopropyl propionamide, glycerol, menthane formyl ethylamine, phenoxyethanol, ethylhexyl glycerol and water.
The preparation is prepared by processing raw materials in multiple steps, and ensures that all the raw materials are fully dissolved by heating, stirring and other modes in each processing process, thereby further ensuring the quality of the product and the sufficiency of the content of effective components.
The preparation is suitable for use around eyes, can quickly nourish eye muscle tissues and brighten skin around the eyes, and can penetrate into cells around the eyes to promote self-repair of cells of part of the eyes, so that the effect of eye skin care is achieved. The product is mild, has no irritation, and has high safety.
Detailed Description
The present invention is further illustrated below with reference to specific examples. It will be appreciated by those skilled in the art that the following examples, which are set forth to illustrate the present invention, are intended to be part of the present invention, but not to be construed as limiting the scope of the present invention. The reagents used are all conventional products which are commercially available.
Example 1:
a method of preparing a daily eye repair formulation, the method of preparation comprising:
s1, selecting 10 parts of butanediol and 0.08 part of menthyl lactate according to corresponding mass parts, mixing, heating to 40 ℃, stirring for 8min until the menthyl lactate is completely dissolved, and obtaining a prepared phase A;
s2, selecting 20 parts of ethanol, 0.8 part of menthol, 0.8 part of borneol and 0.05 part of camphor according to corresponding mass parts, and mixing uniformly for 20min until the menthol, the borneol and the camphor are completely dissolved to obtain a prepared phase B;
s3, selecting 1 part of p-hydroxyacetophenone, 0.8 part of 1, 3-propylene glycol and 0.05 part of caprylyl hydroximic acid according to corresponding parts by weight, mixing, heating to 60 ℃, stirring for 10min until the p-hydroxyacetophenone and the caprylyl hydroximic acid are completely dissolved, and obtaining a preparation phase C;
s4, selecting 0.0001 part of glucose, 0.0001 part of modified corn starch, 0.19 part of plant extract (red sage root extract, pomegranate fruit extract, rosa canina fruit extract, castanea sativa seed extract, cassia tora seed extract, mulberry fruit extract, astragalus mongholicus extract, safflower carthamus extract, coptis chinensis extract, ligusticum wallichii extract, ginseng extract, polygonatum sibiricum extract, divaricate saposhnikovia root extract, bilberry fruit extract, schizonepeta cata extract, medlar extract and chamomile flower extract), 0.8 part of isopropyl palmitate, 0.05 part of hydroxypropyl cellulose, 0.05 part of maltodextrin, 0.001 part of anthocyanin and 0.01 part of lutein according to corresponding parts by mass, mixing, adding deionized water, stirring for 30min until the anthocyanins are completely dissolved, and filtering to obtain a prepared phase D;
s5, selecting 5 parts of water and 0.5 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer according to corresponding mass parts, mixing for 10min to obtain a uniform aqueous solution, adding 0.5 part of allantoin, 10 parts of propylene glycol and 0.05 part of dipropylene glycol, stirring for 5min, heating to 75 ℃, treating for 20min, homogenizing for 3min (the rotation speed is 2000-4000r/min), cooling to 55-60 ℃, adding 1 part of triethanolamine, mixing, and defoaming; cooling to 50-55 deg.C, adding the preparative phase A and the preparative phase C, and mixing for 10-13 min; cooling to 40-45 deg.C again, adding preparative phase B, preparative phase D, 0.005 part of ascorbyl palmitate, 0.08 part of hydroxyphenyl propionamide benzoic acid, 1 part of 1, 2-pentanediol, 1, 2-hexanediol, 0.05 part of methyl diisopropyl propionamide, 0.05 part of glycerol, 0.8 part of menthane formyl ethylamine, 1 part of phenoxyethanol and 0.05 part of ethyl hexyl glycerol, mixing for 20-28min, and filtering with 200 mesh filter cloth.
Example 2:
a method of making a daily eye repair formulation comprising:
s1, selecting 90 parts of butanediol and 30 parts of menthyl lactate according to corresponding mass parts, mixing, heating to 45 ℃, and stirring for 10min until the menthyl lactate is completely dissolved to obtain a prepared phase A;
s2, selecting 130 parts of ethanol, 60 parts of menthol, 60 parts of borneol and 5 parts of camphor according to corresponding mass parts, mixing uniformly for 25min until the menthol, the borneol and the camphor are completely dissolved to obtain a prepared phase B;
s3, selecting 7 parts of p-hydroxyacetophenone, 40 parts of 1, 3-propylene glycol and 4 parts of caprylyl hydroximic acid according to corresponding parts by weight, mixing, heating to 70 ℃, stirring for 15min until the p-hydroxyacetophenone and the caprylyl hydroximic acid are completely dissolved, and obtaining a preparation phase C;
s4, selecting 5.5 parts of glucose, 1.5 parts of modified corn starch, 280 parts of plant extracts (a red sage root extract, a pomegranate fruit extract, a rosa canina fruit extract, a castanea sativa seed extract, a cassia tora seed extract, a mulberry fruit extract, a mongolian milkvetch root extract, a safflower extract, a coptis chinensis extract, a ligusticum wallichii extract, a ginseng extract, a polygonatum sibiricum extract, a divaricate saposhnikovia root extract, a bilberry fruit extract, a schizonepeta herb extract, a medlar extract and a chamomile flower extract), 12 parts of isopropyl palmitate, 1.5 parts of hydroxypropyl fiber, 1.5 parts of maltodextrin, 12 parts of anthocyanin and 11 parts of lutein according to corresponding parts by mass, mixing, adding deionized water, stirring for 35min, completely dissolving, and filtering to obtain a preparation phase D;
s5, selecting 35 parts of water and 20 parts of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer according to corresponding mass parts, mixing for 15min to obtain a uniform water solution, adding 4 parts of allantoin, 90 parts of propylene glycol and 9 parts of dipropylene glycol, stirring for 8min, heating to 85 ℃, treating for 25min, homogenizing for 5min (the rotating speed is 2000-4000r/min), cooling to 55-60 ℃, adding 7 parts of triethanolamine, mixing, and defoaming; cooling to 50-55 deg.C, adding the preparative phase A and the preparative phase C, and mixing for 10-13 min; cooling to 40-45 deg.C again, adding preparative phase B, preparative phase D, 2.5 parts of ascorbyl palmitate, 8 parts of hydroxyphenyl propionamide benzoic acid, 7 parts of 1, 2-pentanediol, 7 parts of 1, 2-hexanediol, 8 parts of methyl diisopropyl propionamide, 8 parts of glycerol, 12 parts of menthane formyl ethylamine, 10 parts of phenoxyethanol and 8 parts of ethylhexyl glycerol, mixing for 20-28min, and filtering with 250 mesh filter cloth.
Example 3:
a method of preparing a daily eye repair formulation, the method of preparation comprising:
s1, selecting 20 parts of butanediol and 1 part of menthyl lactate according to corresponding mass parts, mixing, heating to 40 ℃, stirring for 8min until the menthyl lactate is completely dissolved, and obtaining a prepared phase A;
s2, selecting 30 parts of ethanol, 1 part of menthol, 1 part of borneol and 0.1 part of camphor according to corresponding mass parts, and mixing uniformly for 20min until the menthol, the borneol and the camphor are completely dissolved to obtain a prepared phase B;
s3, selecting 2 parts of p-hydroxyacetophenone, 1 part of 1, 3-propylene glycol and 0.1 part of caprylyl hydroximic acid according to corresponding parts by weight, mixing, heating to 60 ℃, stirring for 15min until the p-hydroxyacetophenone and the caprylyl hydroximic acid are completely dissolved, and obtaining a prepared phase C;
s4, selecting 0.001 part of glucose, 0.001 part of modified corn starch, 0.28 part of plant extract (red sage root extract, pomegranate fruit extract, rosa canina fruit extract, castanea sativa seed extract, cassia tora seed extract, mulberry fruit extract, astragalus mongholicus extract, safflower carthamus extract, coptis chinensis extract, ligusticum wallichii extract, ginseng extract, polygonatum sibiricum extract, divaricate saposhnikovia root extract, bilberry fruit extract, schizonepeta tenuifolia extract, medlar extract and chamomile extract), 1 part of isopropyl palmitate, 0.1 part of hydroxypropyl cellulose, 0.1 part of maltodextrin, 0.01 part of anthocyanin and 0.1 part of lutein according to corresponding mass parts, mixing, adding deionized water, stirring for 30min until complete dissolution, and filtering to obtain a preliminary phase D;
s5, selecting 10 parts of water and 1 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer according to corresponding mass parts, mixing for 10min to obtain a uniform water solution, adding 1 part of allantoin, 20 parts of propylene glycol and 0.1 part of dipropylene glycol, stirring for 5min, heating to 75 ℃, treating for 20min, homogenizing for 3min (the rotating speed is 2000-4000r/min), cooling to 55-60 ℃, adding 2 parts of triethanolamine, mixing, and defoaming; cooling to 50-55 deg.C, adding the preparative phase A and the preparative phase C, and mixing for 10-13 min; cooling to 40-45 deg.C again, adding preparative phase B, preparative phase D, 0.01 part of ascorbyl palmitate, 0.1 part of hydroxyphenyl propionamide benzoic acid, 2 parts of 1, 2-pentanediol, 2 parts of 1, 2-hexanediol, 0.1 part of methyl diisopropyl propionamide, 0.1 part of glycerol, 1 part of menthane formyl ethylamine, 2 parts of phenoxyethanol and 0.1 part of ethylhexyl glycerol, mixing for 20-28min, and filtering with 200 mesh filter cloth.
Example 4:
a method of preparing a daily eye repair formulation, the method of preparation comprising:
s1, selecting 80 parts of butanediol and 20 parts of menthyl lactate according to corresponding mass parts, mixing, heating to 45 ℃, and stirring for 10min until the menthyl lactate is completely dissolved to obtain a prepared phase A;
s2, selecting 100 parts of ethanol, 50 parts of menthol, 50 parts of borneol and 3 parts of camphor according to corresponding mass parts, mixing uniformly for 25min until the menthol, the borneol and the camphor are completely dissolved to obtain a prepared phase B;
s3, selecting 5 parts of p-hydroxyacetophenone, 30 parts of 1, 3-propylene glycol and 2 parts of caprylyl hydroximic acid according to corresponding parts by weight, mixing, heating to 70 ℃, stirring for 10min until the p-hydroxyacetophenone and the caprylyl hydroximic acid are completely dissolved, and obtaining a preparation phase C;
s4, selecting 5 parts of glucose, 1 part of modified corn starch, 200 parts of plant extracts (a red sage root extract, a pomegranate fruit extract, a rosa canina fruit extract, a castanea sativa seed extract, a cassia tora seed extract, a mulberry fruit extract, a mongolian milkvetch root extract, a safflower extract, a coptis chinensis extract, a ligusticum wallichii extract, a ginseng extract, a polygonatum sibiricum extract, a divaricate saposhnikovia root extract, a bilberry fruit extract, a schizonepeta herb extract, a medlar extract and a chamomile flower extract), 10 parts of isopropyl palmitate, 1 part of hydroxypropyl cellulose, 1 part of maltodextrin, 10 parts of anthocyanin and 10 parts of lutein according to corresponding parts by mass, mixing, adding deionized water, stirring for 35min until complete dissolution, and filtering to obtain a preliminary phase D;
s5, selecting 30 parts of water and 10 parts of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer according to corresponding mass parts, mixing for 15min to obtain a uniform water solution, adding 2 parts of allantoin, 80 parts of propylene glycol and 7 parts of dipropylene glycol, stirring for 8min, heating to 85 ℃, treating for 25min, homogenizing for 5min (the rotating speed is 2000-4000r/min), cooling to 55-60 ℃, adding 5 parts of triethanolamine, mixing, and defoaming; cooling to 50-55 deg.C, adding the preparative phase A and the preparative phase C, and mixing for 10-13 min; cooling to 40-45 deg.C again, adding preparative phase B, preparative phase D, 2 parts of ascorbyl palmitate, 6 parts of hydroxyphenyl propionamide benzoic acid, 5 parts of 1, 2-pentanediol, 5 parts of 1, 2-hexanediol, 5 parts of methyl diisopropyl propionamide, 5 parts of glycerol, 10 parts of menthane formyl ethylamine, 8 parts of phenoxyethanol and 5 parts of ethyl hexyl glycerol, mixing for 20-28min, and filtering with 250 mesh filter cloth.
And (4) testing results:
and (4) checking and numbering: GF 01152021429217.
Inspecting the product: yellow emulsion, 35 ml/count.
And (4) checking items: evaluating the safety of the cosmetics; the basis of the inspection is as follows: technical Specifications for cosmetic safety (2015 edition).
And (4) testing results:
and (3) microbial test results:
the data results show that: the detection results of all items in the microbial detection meet the requirements.
And (3) physical and chemical inspection results:
the data results show that: the detection results of all items in the physical and chemical inspection all meet the requirements.
Product inspection: and (4) checking and numbering: 01042100010028
The above results show that: the product meets the requirement of inspection basis (GB/T29665-2013 skin care emulsion).
And (4) checking and numbering: 01042100010030
The above results show that: all detection indexes meet the requirements.
The present invention is not limited to the above alternative embodiments, and any other products in various forms can be obtained by the present invention, and the present invention is within the protection scope of the present invention. The above embodiments should not be construed as limiting the scope of the present invention, and it will be understood by those skilled in the art that modifications may be made to the technical solutions described in the above embodiments, or equivalent substitutions may be made to some or all of the technical features thereof, without departing from the scope of the present invention, and at the same time, such modifications or substitutions may not make the essence of the corresponding technical solutions depart from the scope of the embodiments of the present invention.
Claims (10)
1. The daily eye repair composition is characterized by being mainly prepared from the following raw materials in parts by mass:
0.5-20 parts of acrylic acid (ester)/C10-30 parts of alkyl acrylate cross-linked polymer, 0.5-4 parts of allantoin, 10-90 parts of propylene glycol, 0.05-9 parts of dipropylene glycol, 1-7 parts of triethanolamine, 10-90 parts of butanediol, 0.08-30 parts of menthyl lactate, 20-130 parts of ethanol, 0.8-60 parts of menthol, 0.8-60 parts of borneol, 0.05-5 parts of camphor, 1-7 parts of p-hydroxyacetophenone, 0.8-40 parts of 1, 3-propanediol, 0.05-4 parts of caprylyl hydroximic acid, 0.005-2.5 parts of ascorbyl palmitate, 0.08-8 parts of hydroxyphenylpropionamide benzoic acid, 0.0001-5.5 parts of glucose, 0.0001-1.5 parts of modified corn starch, 0.19-280 parts of plant extract, 0.8-12 parts of isopropyl palmitate, 0.05-1.5 parts of hydroxypropyl cellulose, 0.05-1.5 parts of maltodextrin, 0.001-12 parts of anthocyanin, 0.01-11 parts of lutein, 1-7 parts of 1, 2-pentanediol, 1-7 parts of 1, 2-hexanediol, 0.05-8 parts of methyl diisopropyl propionamide, 0.05-8 parts of glycerol, 0.8-12 parts of menthane formyl ethylamine, 1-10 parts of phenoxyethanol, 0.05-8 parts of ethyl hexyl glycerol and 5-35 parts of water.
2. The daily eye repair composition according to claim 1, wherein the composition is prepared from the following raw materials in parts by mass:
acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer 1-10 parts, allantoin 1-2 parts, propylene glycol 20-80 parts, dipropylene glycol 0.1-7 parts, triethanolamine 2-5 parts, butanediol 20-80 parts, menthyl lactate 1-20 parts, ethanol 30-100 parts, menthol 1-50 parts, borneol 1-50 parts, camphor 0.1-3 parts, p-hydroxyacetophenone 2-5 parts, 1, 3-propanediol 1-30 parts, caprylyl hydroximic acid 0.1-2 parts, ascorbyl palmitate 0.01-2 parts, hydroxyphenylpropionamide benzoic acid 0.1-6 parts, glucose 0.001-5 parts, modified corn starch 0.001-1 part, plant extract 0.28-200 parts, isopropyl palmitate 1-10 parts, hydroxypropyl cellulose 0.1-1 part, 0.1-1 part of maltodextrin, 0.01-10 parts of anthocyanin, 0.1-10 parts of lutein, 2-5 parts of 1, 2-pentanediol, 2-5 parts of 1, 2-hexanediol, 0.1-5 parts of methyl diisopropyl propionamide, 0.1-5 parts of glycerol, 1-10 parts of menthane formyl ethylamine, 2-8 parts of phenoxyethanol, 0.1-5 parts of ethylhexyl glycerol and 10-30 parts of water.
3. The daily eye care composition according to any one of claims 1 to 2 wherein the plant extract comprises a combination of red sage extract, pomegranate fruit extract, rose hip extract, castanea sativa seed extract, cassia tora seed extract, mulberry fruit extract, astragalus mongholicus extract, safflower extract, coptis chinensis extract, ligusticum wallichii extract, ginseng extract, polygonatum rhizome extract, ledebouriella root extract, bilberry fruit extract, schizonepeta herb extract, lycium barbarum extract and chamomile flower extract.
4. A daily eye repair formulation made from the daily eye repair composition of any one of claims 1-2.
5. A method of making the daily eye repair formulation of claim 4 comprising:
s1, selecting butanediol and menthyl lactate according to corresponding mass parts, mixing, heating and stirring until the menthyl lactate is completely dissolved, and obtaining a preparative phase A;
s2, selecting ethanol, menthol, borneol and camphor according to corresponding parts by weight, and mixing uniformly until the menthol, the borneol and the camphor are completely dissolved to obtain a prepared phase B;
s3, selecting p-hydroxyacetophenone, 1, 3-propylene glycol and caprylyl hydroximic acid according to corresponding parts by weight, mixing, heating and stirring until the p-hydroxyacetophenone and the caprylyl hydroximic acid are completely dissolved, and obtaining a preparation phase C;
s4, selecting glucose, modified corn starch, plant extract, isopropyl palmitate, hydroxypropyl cellulose, maltodextrin, anthocyanin and lutein according to corresponding parts by weight, mixing, adding deionized water, stirring until the mixture is completely dissolved, and filtering to obtain a preliminary phase D;
s5, selecting water and acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer according to corresponding mass parts, mixing the mixture to a uniform water solution, adding allantoin, propylene glycol and dipropylene glycol, stirring, heating, homogenizing, cooling to 55-60 ℃, adding triethanolamine, mixing, and defoaming; cooling to 50-55 deg.C, adding the preparative phase A and the preparative phase C, and mixing for 10-13 min; cooling to 40-45 deg.C again, adding preparative phase B, preparative phase D, ascorbyl palmitate, hydroxyphenyl propionamide benzoic acid, 1, 2-pentanediol, 1, 2-hexanediol, methyl diisopropyl propionamide, glycerol, menthane formyl ethylamine, phenoxyethanol and ethylhexyl glycerol, mixing for 20-28min, and filtering.
6. The method for preparing a daily ophthalmic repair preparation according to claim 5 wherein in the step S1, the temperature is heated to 40-45 ℃ and the stirring is carried out for 8-10 min;
in the step S2, the mixing time is 20-25 min.
7. The method for preparing a daily ophthalmic repair preparation according to claim 5 wherein in the step S3, the heating temperature is 60-70 ℃, and the heating and stirring time is 10-15 min;
in the step S4, the stirring time is 30-35 min.
8. The method for preparing a daily eye-rejuvenating formulation as claimed in claim 5 wherein in said S5, the mixing time of water and acrylic/C10-30 alkanol acrylate crosspolymer is 10-15 min;
stirring the allantoin, the propylene glycol and the dipropylene glycol for 5-8min when heating; heating to 75-85 deg.C for 20-25 min;
the homogenizing treatment time is 3-5min, and the rotating speed is 2000-4000 r/min.
9. The method for preparing the daily eye-repair preparation according to claim 5, wherein in S5, 200-mesh and 250-mesh filter cloth is used.
10. Use of the daily eye repair formulation of claim 4 in the preparation of an eye cosmetic.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210507515.5A CN114831916A (en) | 2022-05-10 | 2022-05-10 | Daily eye repair composition, preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210507515.5A CN114831916A (en) | 2022-05-10 | 2022-05-10 | Daily eye repair composition, preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114831916A true CN114831916A (en) | 2022-08-02 |
Family
ID=82570616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210507515.5A Pending CN114831916A (en) | 2022-05-10 | 2022-05-10 | Daily eye repair composition, preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114831916A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116850235A (en) * | 2023-01-06 | 2023-10-10 | 唐建 | Pharmaceutical preparation for removing eye wrinkles and preparation method thereof |
| GB2626306A (en) * | 2023-01-10 | 2024-07-24 | Delsys Tech Limited | Agrochemical compositions |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110787082A (en) * | 2019-09-29 | 2020-02-14 | 广州达达眼健康管理有限公司 | Eye cell repair composition and eye care product containing same |
| CN111419784A (en) * | 2020-05-07 | 2020-07-17 | 深圳市玉莱漫科技发展有限公司 | NMN-containing anti-wrinkle eye cream and preparation method and application thereof |
| CN112618460A (en) * | 2021-01-05 | 2021-04-09 | 叶敏康 | Plant energy eye mask and preparation method thereof |
-
2022
- 2022-05-10 CN CN202210507515.5A patent/CN114831916A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110787082A (en) * | 2019-09-29 | 2020-02-14 | 广州达达眼健康管理有限公司 | Eye cell repair composition and eye care product containing same |
| CN111419784A (en) * | 2020-05-07 | 2020-07-17 | 深圳市玉莱漫科技发展有限公司 | NMN-containing anti-wrinkle eye cream and preparation method and application thereof |
| CN112618460A (en) * | 2021-01-05 | 2021-04-09 | 叶敏康 | Plant energy eye mask and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116850235A (en) * | 2023-01-06 | 2023-10-10 | 唐建 | Pharmaceutical preparation for removing eye wrinkles and preparation method thereof |
| GB2626306A (en) * | 2023-01-10 | 2024-07-24 | Delsys Tech Limited | Agrochemical compositions |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103432024B (en) | Cosmetic composition with function of removing acne | |
| CN114831916A (en) | Daily eye repair composition, preparation method and application thereof | |
| CN101653537B (en) | Ceramide production accelerant | |
| CN111714425B (en) | Shampoo composition for improving scalp and hair condition | |
| CN109528603A (en) | Lightening compositions, whitening brightening cream comprising lightening compositions and preparation method thereof | |
| CN105662973A (en) | Hippophae rhamnoides and rosa rugosa essential oil facial mask essence with moistening and whitening functions | |
| CN107937176A (en) | A kind of high-efficiency antioxidant anti-acne handmade soap | |
| CN108158914A (en) | A kind of Essence of bright color and preparation method thereof | |
| CN109288779A (en) | Anticreep Haircare composition and shampoo | |
| CN112043661B (en) | Whitening aloe gel and preparation method thereof | |
| CN106551868A (en) | A kind of resveratrol multi-effect compound facial film and preparation method thereof | |
| CN110859791B (en) | Skin whitening composition, application thereof and skin whitening mask | |
| CN108785200B (en) | Antibacterial, acne-removing and anti-wrinkle silver ion moisturizing mask liquid, mask and preparation method of mask | |
| CN110433122A (en) | A kind of composition and its application in the skin care item for preparing light speckles, beautification and white | |
| CN109568553B (en) | Traditional Chinese medicine composition for eliminating dark eye circles and preparation method and application thereof | |
| CN104971015A (en) | Facial mask product special for oily skin and preparation method thereof | |
| CN105832611B (en) | A kind of natural plant extracts composition and its preparation method and application | |
| CN105496830A (en) | Preparation method of alpinia japonica extract and application thereof in personal care products | |
| CN106265333A (en) | A kind of Chinese medicament hair dye and preparation and application thereof | |
| CN107823004A (en) | Plant composition with anti-sunlight function and its application in sunscreen product | |
| KR100544024B1 (en) | Skin whitening compound | |
| CN104523530A (en) | Anti-aging facial mask and preparation method thereof | |
| CN106606445A (en) | Walnut oil skin care cream and preparation method thereof | |
| CN110960436A (en) | Skin care composition, eye cream and preparation method thereof | |
| CN111407713A (en) | Ginseng and pilose antler eye ointment and processing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220802 |
|
| RJ01 | Rejection of invention patent application after publication |